Published on 6 Apr 2023 on Insider Monkey via Yahoo Finance

NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q4 2022 Earnings Call Transcript

NovaBay Pharmaceuticals, Inc. (AMEX:NBY) Q4 2022 Earnings Call Transcript March 30, 2023

Operator: Welcome to the NovaBay Pharmaceuticals' 2022 Fourth Quarter and Full Year Financial Results Conference Call. As a reminder, this conference is being recorded. I would now like to turn the conference over to Jody Cain. Please go ahead.

Jody Cain: This is Jody Cain with LHA. Thank you for participating in today's call. Joining me from NovaBay are Justin Hall, Chief Executive Officer and General Counsel and Tommy Law, Interim Chief Financial Officer. I'd like to remind listeners that comments made during this call by management will include forward-looking statements within the meaning of federal securities laws. These forward-looking statements involve risks and uncertainties that could cause actual results to be materially different from any anticipated results. In particular, there is uncertainty about circumstances beyond the company's control that impact the broader economy such as the COVID-19 pandemic and the conflict between Russia and Ukraine. This means that results could change at any time and the contemplated impact of COVID-19 and circumstances that impact the broader economy on NovaBay's operations, its financial results and its outlook is the best estimate based on the information available for today's discussion.